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Abstract
Objectives To test radiomics-based features extracted from noncontrast CT of patients with spontaneous intracerebral haemor-
rhage for prediction of haematoma expansion and poor functional outcome and compare themwith radiological signs and clinical
factors.
Materials and methods Seven hundred fifty-four radiomics-based features were extracted from 1732 scans derived from the
TICH-2 multicentre clinical trial. Features were harmonised and a correlation-based feature selection was applied. Different
elastic-net parameterisations were tested to assess the predictive performance of the selected radiomics-based features using grid
optimisation. For comparison, the same procedure was run using radiological signs and clinical factors separately. Models trained
with radiomics-based features combined with radiological signs or clinical factors were tested. Predictive performance was
evaluated using the area under the receiver operating characteristic curve (AUC) score.
Results The optimal radiomics-based model showed an AUC of 0.693 for haematoma expansion and an AUC of 0.783 for poor
functional outcome. Models with radiological signs alone yielded substantial reductions in sensitivity. Combining radiomics-
based features and radiological signs did not provide any improvement over radiomics-based features alone. Models with clinical
factors had similar performance compared to using radiomics-based features, albeit with low sensitivity for haematoma expan-
sion. Performance of radiomics-based features was boosted by incorporating clinical factors, with time from onset to scan and age
being the most important contributors for haematoma expansion and poor functional outcome prediction, respectively.
Conclusion Radiomics-based features perform better than radiological signs and similarly to clinical factors on the prediction of
haematoma expansion and poor functional outcome. Moreover, combining radiomics-based features with clinical factors im-
proves their performance.
Key Points
• Linear models based on CT radiomics-based features perform better than radiological signs on the prediction of haematoma
expansion and poor functional outcome in the context of intracerebral haemorrhage.
• Linear models based on CT radiomics-based features perform similarly to clinical factors known to be good predictors.
However, combining these clinical factors with radiomics-based features increases their predictive performance.
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AUC Area under the receiver operating characteristic
curve
CTA Computed tomography angiography
GLM Generalised linear model
HE Haematoma expansion
ICH Intracerebral haemorrhage
LASSO Least absolute shrinkage and selection operator
NCCT Noncontrast computed tomography
NPV Negative predictive value
PPV Positive predictive value
TICH-2 Tranexamic acid for intracerebral haemorrhage 2
TSNE t-Distributed stochastic neighbour embedding
Introduction
Haematoma expansion (HE) is a complication that af-
fects around one in five people with spontaneous intra-
cerebral haemorrhage (ICH) during the first 24 h after
symptom onset [1]. Additionally, HE is associated with
poor functional outcome and is a therapeutic target for
improving outcome [2, 3]. Identifying those with a high
risk of HE may allow selective targeting of patients
with high chance of benefit in clinical trials testing
haemostatic therapies.
Computed tomography angiography (CTA) spot sign
has been validated as good predictor of HE in ICH
[4–6]. However, noncontrast computed tomography
(NCCT) is still the standard of care for acute stroke in
most care settings worldwide; thus, CTA is not routinely
performed. NCCT signs such as blend sign [7], black hole
sign [8], hypodensities [9, 10], island sign [11], and swirl
sign [12] have been proposed as alternative predictors of
haematoma expansion and/or poor functional outcome.
Nonetheless, those predictors suffer from intra- and inter-
observer variability, have variable definitions, and present
modest sensitivity. For example, Law et al [13] reported
sensitivities of 11.4–39.5% for haematoma expansion and
14.3–39.2% for poor functional outcome. These limita-
tions highlight the need for alternative quantitative ap-
proaches that are performed automatically and may show
better predictive performance.
A recent meta-analysis found that time from symptom on-
set to baseline CT imaging, baseline intracerebral haemor-
rhage volume, antiplatelet use, and anticoagulant use were
important factors for the prediction of HE in the context of
primary ICH [14]. Despite their importance, these clinical
factors may not cover the full spectrum of predictive informa-
tion that can be obtained from patients. Therefore, providing
an approach that can automatically extract features from im-
ages may provide valuable complementary information to aid
in the prediction.
Radiomics is a relatively recent quantitative approach in
which a large number of features, such as intensity statis-
tics, shape descriptors, or texture measurements, are extract-
ed from radiological images to then be tested as predictors
of outcomes [15, 16]. We hypothesise that radiomics-based
features predict haematoma expansion and poor functional
outcome, since they may capture not only characteristics of
the haematoma known to relate to instability (such as het-
erogeneity or complex shape) but also subtle characteristics
not readily appreciable to the naked eye. Recent studies
have applied a radiomics-based approach to prediction of
HE [17–19]; however, these studies were relatively small
(the largest included just over 250 subjects) and are based
on either a single centre [17, 19] or just 4 centres [18].
While useful to demonstrate the feasibility of the approach,
the generalisability of the results is unclear. In this paper,
we investigate the use of NCCT radiomics-based features
and generalised linear models for prediction of both HE
and poor functional outcome, in a retrospective analysis
of data acquired prospectively in a large international
multicentre randomised controlled trial in ICH. We also
explore the predictive relation of our radiomics-based mod-
el with both radiological signs and clinical factors.
Materials and methods
Intracerebral haemorrhage subjects
We retrospectively included participants recruited pro-
spectively to the TICH-2 international randomised,
placebo-controlled clinical trial (ISRCTN93732214)
[20]. This trial tested the efficacy and safety of intrave-
nous tranexamic acid in people with acute spontaneous
intracerebral haemorrhage presenting within 8 h of symp-
tom onset. Primary outcome was functional status at day
90 measured by modified Rankin scale. Ethical approval
for TICH-2 was obtained from the local institutional re-
view board and informed consent was obtained before
enrolment, either from the participant or one of their
relatives. The rationale, protocol, and inclusion/
exclusion criteria for the TICH-2 trial have been reported
elsewhere [21]. All 2077 TICH-2 trial participants that
had valid baseline and follow-up scans and have been
previously reported [13] were eligible for inclusion in
this analysis. We excluded 345 participants for our anal-
ysis due to clinical and technical reasons (Fig. 1), yield-
ing a total of 1732 participants. Finally, all analyses were
performed on a stratified semi-random split of the partic-
ipants into a training set (N = 1211, 70%) and testing set




Noncontrast CT (NCCT) brain scans were acquired as part of
routine clinical care at each of the 124 centres participating in
TICH-2 following their local protocol. Baseline scans were
acquired before randomisation and follow-up scans were ac-
quired after 24 ± 12 h [21]. There were no restrictions on
scanner manufacturer, scanner settings, or slice thickness.
Nevertheless, only axial scans were accepted.
Feature extraction
The proposed feature extraction process follows the image
processing guidelines of the image biomarker standardisation
initiative (IBSI) [22, 23]. Firstly, semi-automated volumetric
segmentation of intracerebral haemorrhage, perihaematomal
oedema, and intraventricular haemorrhage was performed
from each baseline and follow-up NCCT scans by one of three
independent experienced stroke imaging researchers (Z.K.L.,
K.K., and A.A.), who were blinded to clinical data, using ITK-
SNAP version 3.6.0 (http://www.itksnap.org), with manual
editing as required. The raters also classified each baseline
NCCT scan as positive or negative for the presence of
radiological markers (blend sign [7], black hole sign [8],
hypodensities [9, 10], and island signs [11]). Reliability
assessments for the haematoma volumetric measurement and
radiological marker interpretation for these raters have been
published previously [13].
Secondly, images were resampled to 1-mm isotropic
voxel size and additional filtered versions were computed
using Laplacian of Gaussian and Wavelet filters (see
Supplementary Materials). A total of 754 NCCT
radiomics-based features were subsequently extracted from
the original and filtered scans (see Supplementary
Table S1) using MATLAB R2019b. Seven hundred fifty-
two of them were taken from the area defined as intracere-
bral haemorrhage on the baseline scan, using a third-party
package (https://github.com/mvallieres/radiomics) [24] for
Fig. 1 Study inclusion flowchart
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textural features, and in-house code for first-order and
shape-based features (see Supplementary Materials for
code snippets). The remaining two features correspond to
baseline perihaematomal oedema volume (mL) and base-
l ine intraventr icular haemorrhage volume (mL).
Additionally, we incorporated the TICH-2 treatment allo-
cation (either tranexamic acid or placebo) to the radiomics
features as a covariate of no interest.
Fig. 2 Feature extraction process
flowchart. NCCT scans and their
annotations are resampled to
1mm isotropic. Shape features are
extracted from the resampled
annotations and intensity and
texture features are extracted from
the resampled original and filtered
images. This set of features,
together with ultra-early
haematoma growth are
harmonised and the final set of
uncorrelated features is then
computed using a correlation-
based filtering method. NCCT,
noncontrast computed
tomography; LoG, Laplacian of
Gaussian
Fig. 3 Training and testing
procedure. The training UK data
is split into 10 non-overlapping
folds and 10 different models are
trained for each value of the
hyperparameter α, using each
fold as validation data once. The
model that shows the greatest
AUC is selected for testing using
the non-UK holdout data
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Feature processing
Each feature vector was harmonised using the MATLAB ver-
sion of the ComBat harmonisation package (https://github.
com/Jfortin1/ComBatHarmonization) [25–27] with
parametric adjustments to remove possible batch effects of
slice thickness in the radiomics computation. This method
has already been tested before for harmonisation of NCCT
radiomics [28]. We utilised three batches: (1) slice thickness
< 2 mm; (2) slice thickness ≥ 2 mm and < 4 mm; and (3) slice
thickness ≥ 4mm. Additionally, age and gender were utilised
as biological covariates. Harmonisation was performed first
on the training set and the same parameters were then applied
to harmonise the testing set.
Also, an iterative feature selection procedure was run in
which; for every pair of variables with absolute correlation
> 0.9, the one with the largest mean absolute correlation is
removed. After removing each variable, the average correla-
tions were recomputed for the next iteration. This procedure
was performed on the training data only and reduced the fea-
ture set to 218 unrelated features (see Supplementary
Table S2). Figure 2 depicts the feature extraction process.
Generalised linear model construction
We computed a generalised linear model (GLM) via elastic-
net regularisation [29] with standardisation and log-loss score
as energy function. To this end, we performed an exhaustive
search-grid optimisation procedure with stratified 10-fold
cross-validation (Fig. 3) using the H2O platform v3.26.0.2
(www.h2o.ai) and R software v3.6.3 (www.r-project.org).
This search was carried out over the α blending
hyperparameter of elastic-net regularisation, with values rang-
ing from 0 (Ridge regression) to 1 (LASSO regression) in
increments of 0.1 (see Supplementary Materials). Outcomes
of interest were haematoma expansion, defined as volumetric
growth of > 6 mL or > 33% on the follow-up scan, and poor
functional outcome defined as modified Rankin scale of 4 to
6 at day 90 [20]. Finally, the optimal GLMs were chosen
based on their cross-validation area under the receiver operat-
ing characteristic curve (AUC) score.
For comparison purposes, the same hyperparameter opti-
misation was performed using the presence of radiological
signs alone as binary feature set and also using demographic
and clinical information previously found to be predictive [14,
30]. The radiological markers used were the blend sign, black
hole sign, hypodensities, and island signs. Demographic and
clinical factors were age (years), gender (male/female), time
from onset to baseline scan (hours), baseline haematoma vol-
ume (mL), antiplatelet use (yes/no), and ultra-early
haematoma growth (baseline haemorrhage volume over time
from onset to baseline scan). Anticoagulant use was also
found to be predictive by Al-Shahi Salman et al [14];
however, this was an exclusion criterion of TICH-2 and hence
not included. We also carried out the analysis using
radiomics-based features combined with radiological signs
and with clinical factors independently.
We also assessed our study using the radiomics quality
score [31] (See Supplementary Materials for details). The
score was 13 (36.11%), which is higher than the median score
obtained on a recent systematic review of 51 cancer studies
[32]. One of the main criteria affecting our score was the fact
that despite TICH-2 being a prospective trial, it was not ini-
tially devised with radiomics in mind.
Results
Participant characteristics analysis
Participant demographics are summarised in Table 1 for
haematoma expansion and Table 2 for poor functional out-
come. Of the 1732 participants, 13 had no functional outcome
information available and were excluded from the correspond-
ing analysis. This accounts for the difference in the number of
subjects between Tables 1 and 2. There was no significant
difference in age, gender, or any of the included variables
between training and testing sets (all p > .05). Finally, no
statistical difference (all p > .05) in treatment allocation pro-
portions was found between both sets.
Regarding differences within the training and testing sets,
we observed that baseline haemorrhage volume was signifi-
cantly higher (p < .001) for participants who developed HE
and for those with poor functional outcome in both sets. This
difference remains significant if we test on the whole popula-
tion sample (p < .001). For treatment allocation, we observed a
difference that is not statistically significant between partici-
pants with and without HE on both sets. However, this differ-
ence became significant when tested on the whole population
sample (p = .018). We observed no statistical difference in
poor functional outcome in the training and testing sets, nor
when tested on the whole population sample (all p > .05).
Effect of feature harmonisation
To show the effect of feature harmonisation, we computed a
2-dimensional t-SNE manifold [33] over the standardised fea-
ture vectors of each subject for both the training and testing
sets (Fig. 4). We observed that prior to harmonisation,
there were three clusters corresponding to each of the
harmonisation batches on both sets. This demonstrates the
strong impact of slice thickness on the values of computed
radiomics-based features. After harmonisation, this influence
was eliminated.
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Performance of generalised linear models
Threshold analysis and ROC curves summarising the predic-
tion performance of the optimal models on the training set
using NCCT radiomics-based features, radiological signs,
clinical factors, and combined models are depicted in Fig. 5
for HE and Fig. 6 for poor functional outcome. Individual
AUC, sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and prevalence for
both the training and testing sets are reported in Table 3. For
each optimal model, we chose the threshold probability in the
training set such that Youden’s index defined as sensitivity +
specificity − 1 is maximised. The same threshold was then
used on the testing set.
For prediction of haematoma expansion, a moderate per-
formance was observed when using NCCT radiomics-based
features, with testing set AUC of 0.693 (95% CI, 0.638–
0.747), sensitivity of 0.635 (95%CI, 0.554–0.716), specificity
Table 1 Patient characteristics for the training and testing datasets with respect to haematoma expansion. Data are number (%), mean (SD), or median
(IQR). ‡p value between testing and training datasets









p value p value‡
Number 137 (26.3%) 384 (73.7%) 337 (27.8%) 874 (72.2%)
Age, years 70.03 (13.13) 68.52 (12.95) .244 69.94 (14.26) 68.39 (13.72) .082 .894
Gender, male 82 (59.9%) 211 (54.9%) .367 200 (59.3%) 481 (55.0%) .196 .999
Treatment allocation, placebo 77 (56.2%) 185 (48.2%) .112 183 (54.3%) 424 (48.5%) .073 .950
Baseline volume, mL 20.88 (7.73–40.00) 10.09 (5.12–20.65) < .001 20.84 (7.50–42.98) 10.15 (4.68–20.52) < .001 .851
Onset to CT scan, h 1.73 (1.30–2.51) 2.03 (1.40–3.13) .004 1.80 (1.27– 2.47) 2.00 (1.38–3.00) < .001 .564
Ultra-early haematoma
growth, mL/h
11.06 (4.74–22.37) 5.12 (2.25–10.77) < .001 10.81 (4.32–23.40) 5.04 (2.10–11.68) < .001 .887
Systolic blood pressure, mm Hg 172.01 (30.32) 174.25 (28.78) .440 173.73 (28.58) 176.26 (29.66) .181 .218
Previous antiplatelet therapy 39 (28.5%) 92 (24.0%) .304 98 (29.1%) 194 (22.2%) .013 .647
Blend sign, present 33 (24.1%) 48 (12.5%) .002 79 (23.4%) 89 (10.2%) < .001 .362
Black hole sign, present 30 (21.9%) 49 (12.8%) .013 77 (22.8%) 133 (15.2%) .002 .265
Hypodensities, present 50 (36.5%) 84 (21.9%) .001 134 (39.8%) 209 (23.9%) < .001 .266
Island sign, present 16 (11.7%) 19 (4.9%) .010 37 (11.0%) 51 (5.8%) .003 .683
Table 2 Patient characteristics for the training and testing datasets with respect to functional outcome. Data are number (%), mean (SD), or median
(IQR). ‡p value between testing and training datasets









p value p value‡
Number 258 (49.9%) 259 (50.1%) 643 (53.5%) 559 (46.5%)
Age, years 72.55 (12.30) 65.29 (12.75) < .001 73.10 (12.80) 64.08 (13.52) < .001 .989
Gender, male 128 (49.6%) 164 (63.3%) .002 319 (49.6%) 353 (63.1%) < .001 .826
Treatment allocation,
placebo
130 (50.4%) 129 (49.8%) .930 320 (49.8%) 283 (50.6%) .773 .979
Baseline volume, mL 20.20 (9.79–40.49) 7.27 (3.51–14.51) < .001 18.78 (7.71–42.14) 7.50 (3.36–14.83) < .001 .869
Onset to CT scan, hours 1.89 (1.33– 2.93) 2.00 (1.38– 3.05) .387 1.92 (1.33– 2.75) 1.95 (1.37– 2.83) .178 .497
Ultra-early haematoma
growth, mL/h
10.40 (4.78–20.98) 4.09 (1.52–7.39) < .001 9.65 (4.04–22.61) 3.58 (1.62–8.06) < .001 .865
Systolic blood pressure,
mm Hg
172.26 (28.63) 174.84 (29.81) .316 174.93 (29.14) 176.08 (29.24) .497 .214
Previous antiplatelet
therapy
79 (30.6%) 52 (20.1%) .006 195 (30.3%) 97 (17.4%) < .001 .644
Blend sign, present 49 (19.0%) 31 (12.0%) .029 105 (16.3%) 62 (11.1%) .009 .392
Black hole sign, present 51 (19.8%) 27 (10.4%) .003 147 (22.9%) 61 (10.9%) < .001 .258
Hypodensities, present 87 (33.7%) 46 (17.8%) < .001 233 (36.2%) 107 (19.1%) < .001 .276
Island sign, present 32 (12.4%) 3 (1.2%) < .001 79 (12.3%) 9 (1.6%) < .001 .684
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of 0.690 (95% CI, 0.644–0.736), PPV of 0.422 (95% CI,
0.355–0.49), and NPV of 0.841 (95% CI, 0.801–0.882). The
rather low PPV can be partially explained by an imbalance of
the positive and negative classes, as prevalence was 26.3%
(95% CI, 22.5–30.1%). The most important feature in the
GLM was “LoG-35 interquartile range” (Table 4), which
highlights that haematoma heterogeneity (as measured by
Laplacian of Gaussian-based features) is relevant for predic-
tion. The performance of radiological signs was considerably
lower (Table 3) due to sharp reductions in sensitivity and
AUC on both sets; however, specificities were mildly higher.
Moreover, the optimal model for prediction using radiomics-
based features and radiological signs combined was identical
to the optimal model using radiomics-based features alone, as
all the coefficients for radiological signs were shrunk to zero
by elastic-net training. Also, the optimal model using demo-
graphic and clinical factors yielded slightly lower perfor-
mance than the one using radiomics-based features, especially
due to a sharp reduction in sensitivity to 0.35 (95% CI, 0.27–
0.43). However, combining these factors with radiomics-
based features boosted their performance, achieving an AUC
of 0.704 (95% CI, 0.651–0.758) and an increased sensitivity
of 0.65 (95%CI, 0.57–0.73).We found that time from onset to
CT scan was the factor responsible for this improvement.
Finally, treatment allocation was discarded by elastic net in
all radiomics-based models, showing it had no effect on
predictions.
In the case of prediction of poor functional outcome using
NCCT radiomics-based features, we observed a good perfor-
mance, with testing set AUC of 0.783 (95%CI, 0.744–0.823),
sensitivity of 0.698 (95% CI, 0.642–0.754), specificity of
0.741 (95% CI, 0.688–0.795), PPV of 0.729 (95% CI,
0.673–0.784), and NPV of 0.711 (95% CI, 0.657–0.765).
Here, the balanced prevalence of 49.9% (95% CI, 45.6–
54.2%) is reflected on balanced predictive values.
Perihaematomal oedema volume was found as the most im-
portant factor for prediction, suggesting that inflammation
may have an important effect on clinical outcome. Like the
case of haematoma expansion, both sensitivity and AUC suf-
fered a strong reduction using radiological signs compared to
Fig. 4 TSNE visualisations of standardised training and testing radiomics
feature vectors for each of the 3 harmonisation batches. Each point
represents a feature vector for one subject. The left column corresponds
to subject radiomics feature vectors pre-harmonisation and the right









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5 Threshold analysis for sensitivity, specificity, Youden’s index, F1
score, F0.5 score, and F2 score (left column) and ROC curve (right
column) for the five prediction models of haematoma expansion
(radiomics, radiological signs, radiomics and signs combined, clinical
factors, and radiomics and clinical factors combined). Optimal threshold
criterion was maximal Youden’s index
Eur Radiol
Fig. 6 Threshold analysis for sensitivity, specificity, Youden’s index, F1
score, F0.5 score, and F2 score (left column) and ROC curve (right
column) for the three prediction models of poor functional (radiomics,
radiological signs, radiomics and signs combined, clinical factors, and
radiomics and clinical factors combined). Optimal threshold criterion


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the model trained with NCCT radiomics-based features.
Again, for the case of combined NCCT radiomics-based fea-
tures and radiological signs, we obtained a model which was
identical to the one trained using NCCT radiomics-based fea-
tures alone. Moreover, demographic and clinical factors
showed slightly better AUC than NCCT radiomics-based fea-
tures, explained by an improved specificity. Again, by com-
bining these factors and NCCT radiomics-based features, the
best performance is achieved, with an AUC of 0.818 (95%CI,
0.781–0.854), mainly due to increased PPV andNPV of 0.799
(95% CI, 0.747–0.852) and 0.73 (95% CI, 0.68–0.781), re-
spectively. The features accountable for this improvement
were age and ultra-early haematoma growth. Lastly, treatment
allocation had again no influence on the radiomics-based
models and was discarded by elastic net.
Discussion
We evaluated the predictive performance of NCCT
radiomics-based features for haematoma expansion and
poor functional outcome using generalised linear models
on a large and heterogeneous sample. We also investigat-
ed the predictive performance of radiological signs and
clinical factors, and their combination with radiomics-
based features with the same type of models. This analy-
sis evidenced that radiomics-based features have higher
predictive performance compared to radiological signs
and perform similarly to clinical factors. Moreover, this
work showed that prediction performance is not improved
by incorporating radiological signs, but it is boosted by
the inclusion of demographic and clinical factors.
Since our analyses are based on binary outcomes,
haematoma expansion and the modified Rankin scale were
dichotomised. Our choice of dichotomisation for haematoma
expansion was identical to that of the TICH-2 trial [20] and
has also been used in several retrospective analyses [10,
34–36]. Our choice for the modified Rankin scale is based
on the observation that intracerebral haemorrhage is in general
a severe type of stroke and a score of 3 or less would still be
considered a “good” outcome. This choice has also been pre-
viously made for the primary analysis of large clinical trials of
ICH, such as STICH [37] and CLEAR III [38].
Our reported diagnostic performance of radiological signs
was not identical to a previous work using data from the
TICH-2 clinical trial [13]. The main sources of difference
were that our study included fewer participants and that we
performed the analysis using the combined set of signs as
predictor features simultaneously, rather than testing each
one individually. Nevertheless, our results are consistent with
this previous report in terms of the relatively low sensitivity
showed by these signs.
In addition to their poor sensitivity, radiological signs are
qualitative measures with subjective definitions and are there-
fore susceptible to inter- and intra-rater variability. On the
other hand, the proposed radiomics-based generalised linear
model provides a quantitative and consistent way of
predicting HE and poor functional outcome, yielding better
sensitivity and AUC. However, despite the performance of
our radiomics approach, it is not currently available for real-
time application and would require significant further devel-
opment and validation for clinical use.
Many important variables selected by our radiomics-based
model are consistent with previous findings. Amongst them
are features based on Laplacian of Gaussian filters, which are
indicative of haematoma heterogeneity and have good predic-
tive value for its expansion [39], and extent of perihaematomal
oedema, which has a predictive association with poor func-
tional outcome [40, 41]. Also, our observation that the addi-
tion of the time from symptom onset to baseline scan to our
radiomics-based model improves HE prediction is consistent
with the meta-analysis by Al-Shahi Salman et al [14]. Finally,
the conclusion that incorporating age and ultra-early
haematoma growth as factors substantially improves function-
al outcome prediction has strong support in prior studies [30,
42, 43].
An important aspect of constructing a NCCT radiomics-
based model for prediction is the harmonisation of the extract-
ed raw features. This is especially crucial in the context of data
coming from multicentre studies such as TICH-2, where the
stability of the radiomics features can be severely affected by
differences in imaging protocols [44]. Our investigation sug-
gests that slice thickness is a very important factor to consider
for harmonisation, which is in agreement with previous find-
ings [45]. However, there are additional relevant sources of
difference (for which we had no exhaustive information) that
could have been considered such as scan type (helical/axial),
slice gap, reconstruction kernel, field of view, tube voltage,
and milliamperage [46]. Future radiomics studies should take
all these sources of variability into account to achieve optimal
harmonisation.
A relevant observation is that our model does not reach the
same predictive performance for HE as recent studies using
radiomics-based linear models [18, 19] that show substantially
better performance. This may be due to those studies being
performed on significantly smaller samples from 4 or fewer
centres which may have much lower variability in terms of
CT parameters. This highlights the challenges that radiomics-
based models face when dealing with data that better reflects
the “real-world” variability present in multicentre studies. In
order to provide a reliable tool for research and clinical appli-
cation, it is also essential to tackle the current challenge of
reproducibility in advanced clinical imaging. In radiomics, po-
tential sources of variability arise from image pre- and post-
processing, discrepancies in the way the segmentation of
Eur Radiol
regions of interest is performed, and differences in the number
and type of radiomics computed. Standardisation efforts such
as IBSI [22] are a step in the right direction and should be
adopted in future radiomics studies. Furthermore, we have
found beneficial to perform post-harmonisation of discrepant
features when protocol homologation amongst many centres is
not feasible or practical, like in the case of our study.
Finally, this is a first approach using elastic net, where the
linear contributions of each feature can be assessed in a
straightforward manner. Other machine learning approaches,
such as random forest or deep learning, can be investigated to
improve the detection of non-linear interactions between var-
iables and potentially improve prediction performance. For
example, a comparison of different classifiers similar to the
one performed by Li et al [17] may be pursued, but in a much
larger sample.
In conclusion, we showed that models using NCCT
radiomics-based features outperform models using radiologi-
cal signs or clinical factors. However, we found that incorpo-
rating demographic and clinical factors into a radiomics-based
model substantially improves the prediction. These results
suggest that radiomics-based models, with added demograph-
ic and clinical factors if available, may be of prognostic value
in people with ICH. Hence, they could be incorporated into
therapeutic trials to aid selection of those at risk of haematoma
expansion or poor functional outcome once further work has
been performed to address the challenges around predictive
accuracy and variability of radiomics features in multicentre
studies.
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